Jamrex Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.81 M
- Revenue Growth 36.13%
- Profit Growth 1.70%
- Ebitda 88.47%
- Net Worth 68.18%
- Total Assets 96.76%
About Jamrex Biotech
Jamrex Biotech Private Limited (JBPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 December 2018 (Six years and two months 18 days old ). Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.81 M.
Horairajilani Khan, Ravindra Singh, and Mohd Atahafeez serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85190UP2018PTC110916
- Company No.
110916
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Dec 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Jamrex Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Horairajilani Khan  | Director | 05-Dec-2018 | Current |
| Ravindra Singh | Director | 05-Dec-2018 | Current |
| Mohd Atahafeez | Director | 05-Dec-2018 | Current |
Financial Performance of Jamrex Biotech.
Jamrex Biotech Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 36.13% increase. The company also saw a slight improvement in profitability, with a 1.7% increase in profit. The company's net worth Soared by an impressive increase of 68.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jamrex Biotech?
In 2020, Jamrex Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jamrex Remedies Private LimitedHorairajilani Khan is a mutual person
- Sidza Healthcare Private Limited
Ravindra Singh is a mutual person
Charges (Loans)
₹1.81 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.18 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Feb 2021 | Hdfc Bank Limited | ₹1.81 M | Open |
How Many Employees Work at Jamrex Biotech?
Unlock and access historical data on people associated with Jamrex Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jamrex Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jamrex Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
